Introduction
Adults 65 years and older present with increased incidence of respiratory, urogenital, and gastrointestinal infections, higher susceptibility to autoimmune disease, and mortality resulting from these challenges [1, 2] . The incidence of Clostridium difficile associated diarrhea in older adults is almost 10-fold higher than in younger individuals, and mortality during an outbreak can be as high as 17%, depending on the vulnerability of the patient and virulence of the individual strain [3, 4] . Similarly, the incidence of community-acquired pneumonia as a consequence of viral infections is highest among the very elderly (over 80 years of age) [5] with mortality rates as high as 75% [6] . Mortality rates in the very elderly to rhinovirus, influenza, and streptococcus pneumonia are 20-fold higher as compared to younger adults (45-64 years of age) [7, 8] .
Contributing to higher mortality rates in infectious disease are impaired cell-mediated immunity, which also contributes, in the case of influenza, to poor responses to vaccination [9] . Trivalent influenza vaccines have been shown to convey protection in approximately 50% of the elderly population (age 65+), compared to 70% in adults younger than 65 years [10, 11] .
These aging-associated changes in the immune system have been referred to as immunosenescence [12] or, perhaps more accurately (because immune function is not only impaired but changed), as SIR [13, 14] . SIR impacts on both innate and adaptive immunity. Elderly patients present have altered ratios of CD4 + :CD8 + T cells in peripheral blood [15] . This ratio is termed the immune risk profile (IRP), and a higher IRP has been shown to correlate with clinically defined frailty and disease, but not with healthy aging; centenarian survivors have an IRP similar to younger adults [16] . Age-related alterations in innate immunity are often associated with high levels of inflammation, often referred to as inflammaging. Clinically, inflammaging can be a major contributor to aging-associated disease in non-hematopoietic tissues [17, 18] .
We review here current understanding of the cellular and molecular mechanisms that underlie SIR. In particular, we examine the contribution of aging of HSCs to SIR, and discuss rejuvenation of aged HSCs as a potential approach towards the amelioration of SIR.
Trends
Thymic involution in SIR does not preclude maintenance of a naïve T cell pool upon aging. This implies that attenuation of SIR and restoration of a young naïve T cell pool do not require attenuation of thymic aging.
Large epidemiological studies on the oldest adults demonstrate a strong correlation between markers of inflammaging and frailty, but not for example between chronic CMV infection and frailty, indicating a crucial role for inflammaging in the clinical manifestations of SIR.
SIR is already initiated by aging of HSCs, the stem cells that form most immune cells. Aged HSCs display, among others, enhanced differentiation into myeloid cells at the cost of differentiation into functional lymphoid cells.
Aging of HSCs is reversible, thus rejuvenation of HSCs to attenuate or even revert SIR is a novel therapeutic option for further investigation.
Senescent Immune Remodeling: Cellular Mechanisms
A hallmark of aging-associated SIR is a reduction in the number of naïve T cells [19] and overall changes in the numbers of lymphocyte populations (remodeling), including a reduction in the number of both helper/inducer (CD4 + ) and suppressor/cytotoxic (CD8 + ), as well as CD19 + B cells [19] . An inversion of the ratio of CD4 + to CD8 + T cells in peripheral blood [15] is observed in some elderly individuals, as well as an increase of activated T cells (CD3 + HLA-DR + ) and T lymphocytes expressing natural killer cell (NK) markers [20] . Aging-associated changes in T and B cells and potential clinical implications of these are summarized in Table 1 .
Aging-associated changes in the naïve T cell population -both in terms of total numbers and antigen receptor repertoire -has been thought to be primarily a consequence of thymic involution, but recent studies have questioned this notion (reviewed in [21] ). The amount of T cell receptor excision circles (TREC) in peripheral blood, a surrogate measurement of thymic function, was found to exponentially decline with age [22] . However, mathematical models have suggested that a decrease in thymic production cannot solely account for the reduction in TREC with age [23] . In line with these findings, Braber et al. could show that, in humans, the naïve T population is largely maintained via cell division of naïve T cells in the periphery upon aging [24] . High initial diversity in the T cell pool in young animals, in combination with little impact of thymic output on the peripheral naïve T cell pool [25] , support a model in which proliferation of the T cell pool in humans in the periphery is crucial, but only starts to contribute to this peripheral pool in older adults [26] . This proliferation in the periphery is probably driven by the age-constant levels of interleukin (IL)-7, tonic T cell receptor (TCR) signals, and other hemostatic cytokines [26] . In addition, recent studies based on TCR sequencing and TREC analyses indicate that the extent of the contraction of the TCR repertoire upon aging might have been overestimated [27] . Finally, the peripheral repertoire in the elderly is also affected by selection of highly-reactive clones in the periphery. For example, highly-responsive naïve CD8 + cells in the periphery of older adults might competitively override any new selected naïve cells emigrating from the thymus, irrespective of its functional decline [28] , which will further contribute to the reduced repertoire in older adults. Thus, the impact of thymic involution on the maintenance of a diverse and reactive naïve T cell pool is not fully clear, and neither is the extent to which naïve T cell numbers and repertoire diversity are diminished with aging. A more precise understanding of the contribution of thymic involution to the peripheral T cell pool in healthy adults will be a prerequisite to evaluating its contribution to SIR. In examining the contribution of thymic involution to the peripheral T cell [43] [44] [45] 83] repertoire, it will be important to take into account the notion that aging may be associated with increased sensitivity of naïve T cells to apoptosis (reviewed in [29] Cytomegalovirus (CMV) infection is considered an environmental contribution to SIR because latent CMV infection in the very elderly (86-94 years of age) has been associated with a nonfavorable IRP [32] , and the frequency of CMV-specific CD8 T cells is highest in older adults [33] . It has been speculated that the filling of the 'immunological space' with CMV-specific T cells may constrict the T cell repertoire and strongly impact on the memory compartment, and that these effects may be relevant to SIR [34] . In support of this notion, latent CMV infection in mice indeed resulted in pronounced changes in the T cell compartment consistent with impaired naïve T cell function [35] ; however, these studies were not performed in aged mice. The peripheral naïve T cell population in humans not infected with CMV exhibited a higher number of naïve T cells and a lower CD4/CD8 ratio [36] . However, CMV seropositivity and pathophysiology associated with SIR, such as inflammation, are not consistently linked [37] , and CMV seropositivity does not always result in reduced immune competence in older adults [36] . Thus, the impact of CMV infection on SIR remains to be further defined.
With regards to the regulatory T cell (Treg) compartment, multiple studies provide evidence for the accumulation of FOXP3 + (forkhead box P3) Treg cells with age ( [38] ). However, the functional relevance of this increased representation in peripheral blood to immune competence in the elderly and its impact on SIR are not clear. Recent epidemiological studies reported a positive correlation between long-term (8 year) survival of the very elderly and a higher frequency of CCR4 + Treg cells [38] . Aging also results in alterations in the balance between type 1 T helper cell (Th1) and Th2 immune responses, as determine by measurement of cytokine profiles of peripheral blood mononuclear cells (PBMCs), with the very elderly presenting a skewing towards a Th2 profile, although both Stem cell self-renewal potential Both aged murine and human HSCs display reduced serial transplantation ability compared to young HSCs, implying reduced stem cell self-renewal potential [86] Polarity Aged murine HSCs present with apolarity [87] . Interestingly, polarity was recently also described as a hallmark of functional memory T cells [88] stem cells (HSCs) switches from a canonical b-catenin-dependent pathway to a non-canonical pathway associated mainly to WNT5a [69] . This again increases the activity of the small RhoGTPase CDC42 and results in an increase in Ca 2+ levels (or induction of JNK pathways) to regulate transcription factors such as NFAT. There seems to be substantial WNT/NOTCH crosstalk resulting in upregulated intrinsic NOTCH signaling and less polarity. Apolarity might be linked to the mode of the cell division and thus fate of the daughter cells. These changes in polarity could also be influenced by downregulation of the global chromatin regulator SAT1B with aging [89] and by changes of cytokines in the niche (i.e., CXCL12) [90] . Potential modification targets that have been identified so far are CDC42 inhibitor (CASIN) [54] , SAT1B [89] , WNT pathways [67, 69, 91] , and calcium signaling (e.g., via physical activity [91] ). With respect to the later stages of T cell development, interferon (IFN)-g and IL-4 were expressed at higher amounts in CD4 + and CD8 + T cells of aged as compared to young individuals after in vitro stimulation [40, 41] . Interestingly, with respect to possible clinical interventions, there seems to be a correlation between the magnitude of this shift and zinc deficiency. Zinc deficiency is common in the elderly and is known to result in decreased production of Th1 cytokines, and zinc supplementation might thus alleviate some of the underlying shift towards Th1 responses upon aging [42] .
Aging appears to result in a reduced diversity of naïve B cells (IgD + CD27 À ), but no significant changes in the number of peripheral B cells, suggesting that the impact of aging on the B cell compartment may be primarily qualitative (reviewed in [43] ). Spectratyping analyses reveal a constriction of the B cell repertoire with aging, which correlates with a narrowing of the spectrum of antibody responses and correlated with frailty and susceptibility to infection [44] . A correlation between Epstein-Barr virus (EBV) seropositivity and B cell clonal expansion in the very elderly (80 years and older) has also been reported, although this is not linked to persistent CMV infection [45] . Most humoral immune responses require cognate T cell help and, as noted above, SIR is associated with alterations in the CD4 + compartment; however, how SIR-associated alterations in CD4 + cells relate to changes in B cell responses in the elderly has not been directly examined.
Inflammaging: A Systemic Issue
Older adults frequently present with a systemic chronic low-grade inflammation that has been termed 'inflammaging' [46] . Inflammaging is characterized by increased levels of proinflammatory cytokines [IL-1, IL-6, IL-8, tumor necrosis factor (TNF)-/ and C-reactive protein (CRP)] and is associated with an increased risk of morbidity, mortality, sarcopenia, and frailty. Epidemiological studies have provided the strongest evidence for inflammaging, notably the Newcastle study that examined a large cohort (n = 845) of adults aged 85 years or more; interestingly, this study revealed no correlation between frailty and CMV serum-positivity or IRP [47] [48] [49] . Proinflammatory cytokines associated with inflammaging are thought to be involved in the pathophysiology of cardiovascular and neurodegenerative diseases [50] . However, the cellular sources of these cytokines are not known. The alterations in lymphocyte compartments associated with SIR may play a role, but this has not been demonstrated. Senescent fibroblasts have been shown to produce inflammatory cytokines in some contexts, and approaches towards reducing the senescence associated secretory phenotype (SASP) of these cells, such as manipulation of the NLRP3 (NLR family, pyrin domain containing 3) inflammasome-dependent proinflammatory cascade [51] and inducible deletion of p16 + (cyclin-dependent kinase inhibitor 2A/CDKN2A) senescent cells [52] , impact on systemic inflammation associated with aging in mice. How the production of inflammatory cytokines by senescent cells relates to SIR and alterations in lymphocyte compartments remains to be examined.
HSC Aging: The Beginning of SIR?
In the young, hematopoietic stem cells (HSCs) provide a balanced output of myeloid and lymphoid progenitor cells, which in turn give rise to the innate and adaptive immune compartments. Aging in both humans and mice results in a shift from lymphoid to myeloid differentiation, with a bias of aged HSC towards differentiation into common myeloid progenitor cells (CMPs) particular cytokines such as IL-7, IL-12, IL-15, and IL-22, as well as growth factors such as KGF (important for the stability of the thymic microenvironment), have been identified as potential targets for restoring T cell function, immunity, and response to vaccination [14] . Notably, in these stages SAT1B also seems to be crucial for Th2-type T cell development in a (canonical) WNT-dependent manner [92] . Potential novel and currently used targets for attenuation of SIR are marked in green. Abbreviations: CDC42, cell division cycle 42; CXCL12, chemokine CXC motif ligand 12; IL, interleukin; JNK, c-Jun Nterminal kinase/mitogen-activated protein kinase 8 (MAPK8); KGF, keratinocyte growth factor/fibroblast growth factor 7 (FGF7); LEF, lymphoid enhancer-binding factor 1; NFAT, nuclear factor of activated T cells, cytoplasmic, calcineurindependent; SAT1B, spermidine/spermine N1-acetyltransferase 1B; TCF1, transcription factor 1; Th2, type 2 T helper cell; WNT, wingless/int. and a concomitant reduction in the frequency of common lymphoid progenitor cells (CLPs); this ultimately results in decreased B and T cell lymphopoiesis upon aging [53, 54] (Table 2 and Figure 1 ). Clonal expansion of individual HSCs within the HSC pool in the bone marrow as an individual ages has also been reported [55] , and it is tempting to speculate that the clonality that arises in mature immune effector cells might be at least in part a consequence of the clonality seen in the HSC compartment in aging. It is currently unclear whether the aging-associated myeloid bias of hematopoiesis is a consequence of such a clonal shift, or whether aging directly impacts on the differentiation potential of HSCs themselves [53] . Further downstream, impaired differentiation in the lymphoid lineage upon aging is linked to impaired IL-7 stimulation of CLPs owing to lower levels of both IL-7, reduced expression on IL-7 receptor (IL7-R) on T cell progenitors [56] and reduced expression of differentiation regulators such as NOTCH 1 and GATA3 (GATA binding protein 3) in HPSCs [57] . Aging is associated with reduced differentiation of CLPs into the B cell lineage and reduced expression of the B lineage-specifying factors (early B cell factor, EBF; and paired box 5, Pax5); transduction of CLP from older mice with a constitutively active form of STAT5 (signal transducer and activator of transcription 5) restored both EBF and PAX5 expression and increased B cell potential [58] .
Aging has also been shown to impact on T cell function. The expression of miR-181a in naïve CD4 + T cells in older adults is reduced as compared to younger individuals, and this reduction is associated with decreased TCR sensitivity. miR-181a regulates the expression of DUSP6 (dual specificity phosphatase 6), a cytoplasmic phosphatase that targets phospho-ERK (extracellular signal-regulated kinase) downstream from the TCR, and increasing the expression of miR181a in CD4 + T cells from older adults restored TCR signaling [59] . miRNAs exert multiple regulatory roles in HSC self-renewal and differentiation [60] , and thus it will be of interest to determine whether aging-associated changes in miRNAs contribute to SIR.
HSCs express cell surface receptors associated with inflammation such as Toll-like receptors (TLRs) and purinergic receptors [61] . Mice treated with low doses of lipopolysaccharide (LPS) exhibited myeloid skewing and impaired serial transplantation, suggesting that this treatment resulted in premature HSC aging [62] . The functional significance of this is not clear; it could be speculated that, upon pathogen challenge, the rapid production of myeloid cells may present an advantage to the organism. Cytokines associated with inflammaging such as TNF/, IFN-/, IFNg, and IL-6 have been shown to reduce HSC self-renewal potential and result in myeloid skewing [63, 64] . For example, repeated treatment of mice with poly-IC, which induces expression of IFN-/ and IFN-g in the bone marrow, resulted in HSC exhaustion and bone marrow failure [65] . Recently, a contribution of cytokines associated with cellular senescence (SASP) to the aging of HSCs has been reported [66] . Thus, SIR may result from a cycle that involves inflammation and HSC aging, but the relative contributions of each of these factors and the mechanisms involved remain to be determined.
There is some insight into molecular pathways that may have relevance to aging HSCs and their subsequent impact on SIR. Age-associated changes in WNT (wingless/int) signaling appear directly related to T cell lineage differentiation. Human HSCs exhibit reduced levels of b-catenin upon 'aging' in in vitro cultures, and this correlated with impaired or delayed differentiation of an early T progenitor cell subset [67] . The NOTCH pathway, a potential negative regulator of stem cell aging [68] , is modulated by non-canonical Wnt signaling; aged murine HSCs express high amounts of NOTCH1 and the NOTCH target gene Hes1 (Hes family BHLH transcription factor 1), and this NOTCH signature can be induced by expression of WNT5a in young HSCs [69] . The WNT and NOTCH pathways may also play a role in aging-associated bias towards NK cell differentiation in both humans and mice [70] . The small RhoGTPase CDC42 (cell division control 42) has been identified as a key regulator downstream of the non-canonical Wnt pathway. CDC42 activity increases in the bone marrow and other tissues with age, and this increase has been causally linked to HSC polarity, differentiation, engraftment, and aging [54] . The elevated activity of CDC42 in aged HSCs seems to be a direct consequence of increased stem cellintrinsic expression of WNT5A and, thereby, a shift from canonical to non-canonical Wnt signaling [69] . The mechanism by which WNT5A expression in aged HSCs is induced remains largely unknown, but possibly involves epigenetic modifications [71] .
Taken together, the available evidence supports a model wherein SIR starts at the level of aging of HSCs (Figure 1) , and aging of HSCs contributes to multiple aspects of the clinical presentation of SIR.
Concluding Remarks
What can be done to overcome at least some of the problems of aging or disease-associated immune remodeling to improve therapeutic shortcomings such as vaccination failure or failure to clear systemic infections (see Outstanding Questions)? SIR correlates with multiple changes in the immune system, ranging from aging of stem cells to changes in the number and function of multiple types of effector and regulatory cells. So far, clear mechanistic and thus causal relationships in SIR are difficult to pinpoint. The identification of cellular and molecular mechanisms is a prerequisite for developing successful targeted therapies to attenuate SIR. Approaches that are proven to ameliorate SIR in the clinic therefore are currently primarily behavioral approaches such as exercise (Box 1 and [72] ). Moderate exercise (5 days per week for 6 months) improved CD28 expression on T cells and improved the Th1/Th2 balance [73] . Regular exercise in older adults was also correlated with an improved Th1/Th2 cytokine balance, reduced levels of proinflammatory cytokines, changes in the naïve/memory cell ratio, and increased antibody titers upon influenza vaccination [74] . Interestingly, some nutritional interventions in the clinic have been reported to correlate with better overall immunity and improved Th1/Th2 balance in older adults, such as zinc, probiotics, and vitamin D (Table 2) . However, how such interventions target the cellular or molecular mechanisms of SIR are unknown.
Cytokines crucial for thymic development {IL-7 [75] , KGF (keratinocyte growth factor/fibroblast growth factor 7 FGF7) [76] , IL-22 [77] , and ghrelin [78] } have been already tested in mice for attenuating the loss of function of the thymus upon involution. Some of the factors (IL-7, KGF) demonstrated good success in attenuating at least in part the loss of thymic function with aging (summarized in [79] ). Currently, however, no human trials are ongoing to test these factors for efficacy in preventing thymic loss of function with aging. This might at least in part also reflect the fact that it is still not fully clear whether thymic involution in humans makes a central contribution to SIR, as discussed earlier.
Box 1. Interventions Aimed at Attenuating Diseases Associated with SIR
Clear Evidence Physical Activity/Exercise: can have strong positive effects on overall immunity. Activity was shown to reduce inflammation and prevent senescent cell accumulation in older adults [93] .
Preliminary Evidence
Zinc: decreased inflammaging markers [94] and better T cell development, reducing the shift from Th2 to Th1 and improving vaccination response [95] .
Vitamin D: associated with better overall immunity [96] .
Probiotics: recent studies with particular strains of lactobacilli reveal less inflammation and more NK and immature T cells in older adults [97] .
Future Therapies
Novel cellular and pharmaceutical interventions rejuvenating hematopoietic stem and progenitor cells via pharmacological compounds that target MTOR (mechanistic target of rapamycin) or CDC42 activity [54] or via a periodic diet that mimics fasting [98, 99] , which might be combined with IL-7 and IL-7-related therapies [75] Because SIR is already initiated by aging of HSCs, rejuvenating HSCs to ultimately increase the number of functionally young and thus relevant adaptive effector cells from the B and, probably more importantly, T cell lineages might be a novel approach to attenuate SIR. Whether intervention to increase the production of younger lymphocyte progenitors, and later of T cells, would result in sufficient naïve cells that are functional for stimulating T cell-dependent responses to antigens in the absence of a fully functional thymus in older adults will need to be evaluated in detail. To date, pharmacologic interventions that target intrinsic mechanisms of HSC aging are limited to the use of rapamycin [80] and the CDC42 activity inhibitor CASIN [54] while, more recently, temporary fasting in mice was shown to attenuate aging of HSCs in vivo [81] . For CASIN, selective CDC42 inhibition restored not only HSC polarity but also their lymphopoietic potential, suggesting that this could also be a promising approach to attenuate SIR. CASIN also reverted levels and patterns of histone H4 acetylation from old HSCs to patterns that resembled young HSCs [54] , which implies epigenetics as a novel driving force in stem cell aging, and suggests also that specific histone methylation or acetylation patterns might someday represent therapeutic targets in SIR. Because SIR is an important factor in the elevated morbidity and mortality of older adults, as well as frailty in the clinic, there is continued need to better understand the molecular mechanisms of aging of the immune system. Novel animal model systems, such as mice humanized with respect to hematopoiesis and the immune system, might further support the translation of novel findings into the clinic to promote healthy aging. 
